SCHEMBL21177572

SCHEMBL21177572

CN(C)C=C(C#N)C(=O)N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
USP2 O75604 1/20 0.42
CYP2C9 P11712 1/20 0.40
LMNA P02545 1/20 0.40
CTSK P43235 1/20 0.38
KMT2A Q03164 4/20 0.37
RAB9A P51151 1/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
TGM2 P21980 1/20 0.37
EPHX2 P34913 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27299790 0.83 USP2 (0.44) SMN1; SMN2USP2LMNACTSKKMT2A
SCHEMBL19397802 0.76 HPGD (0.50) SMN1; SMN2USP2KMT2AMEN1ALDH1A1
SCHEMBL21184102 0.75 LMNA (0.44) SMN1; SMN2CYP2C9LMNAKMT2ARAB9A
SCHEMBL28554525 0.75 ALDH1A1 (0.67) SMN1; SMN2KMT2ARAB9AMEN1ALDH1A1
SCHEMBL4739622 0.74 CYP2C9 (0.59) SMN1; SMN2CYP2C9LMNAKMT2ARAB9A
SCHEMBL4739623 0.74 CYP2C9 (0.59) SMN1; SMN2CYP2C9LMNAKMT2ARAB9A
SCHEMBL698803 0.73 USP2 (0.69) SMN1; SMN2USP2LMNAKMT2AMEN1
SCHEMBL18294 0.73 USP2 (0.69) SMN1; SMN2USP2LMNAKMT2AMEN1
SCHEMBL19397798 0.72 MEN1 (0.45) SMN1; SMN2USP2CTSKKMT2AMEN1
SCHEMBL28557984 0.72 EGFR (0.76) SMN1; SMN2USP2LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118754861-A Substituted alkynylene compounds as anticancer agents 奥里吉恩肿瘤学有限公司 2024-10-11 CN disclosed
CN-111902403-B Substituted alkynylene compounds as anticancer agents 奥里吉恩发现科技有限公司 2024-05-17 CN disclosed
EP-3740473-A1 SUBSTITUTED ALKYNYLENE COMPOUNDS AS ANTICANCER AGENTS Aurigene Discovery Technologies Limited (IN) 2020-11-25 EP disclosed
CN-111902403-A Substituted alkynylene compounds as anticancer agents 奥里吉恩发现科技有限公司 2020-11-06 CN disclosed
WO-2019142126-A1 SUBSTITUTED ALKYNYLENE COMPOUNDS AS ANTICANCER AGENTS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2019-07-25 WO disclosed